| CEO: | Peter Collins |
| Executive Chairman: | Jan Groen |
| Senior Independent Director: | Klaas de Boer |
| Non-Executive Dir: | Benjamin Hart , Kim Oreskovic |
| Address: | 10 Nugent Road, Surrey Research Park, Guildford, Surrey, United Kingdom, GU2 7AF |
| Phone: | +44 (0)1483 343434 |
| Website: | http://cellbxhealth.com |
| Sector: | Support(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB0034330679 |
| Currency | UK Pounds |
| Share Price | 1.25p |
| Change Today | -0.075p |
| % Change | -5.66 % |
| 52 Week High | 7.50 |
| 52 Week Low | 0.82 |
| Volume | 2,521,803 |
| Shares Issued | 1,139.40m |
| Market Cap | £14.24m |
| Beta | 0.02 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:28 | 7,500 @ 1.28p |
| 16:20 | 419,405 @ 1.28p |
| 16:17 | 15,254 @ 1.29p |
| 16:14 | 156,734 @ 1.21p |
| 16:06 | 297,942 @ 1.23p |
You are here: research